Biological Input Output Systems

Country:
USA
Founding year:
2021

Biologic Input Output Systems, Inc (BIOS) is a neurotechnology company focused on creating advanced neural interface systems that bridge the peripheral nervous system with robotic and digital technologies. The company’s core technology, the Universal Neural Interface (UNI), is designed to decode neural signals and deliver sensory feedback to enable intuitive control of prosthetic limbs and other assistive devices.

The BIOS platform combines implantable electrodes, AI-enhanced signal decoding, and real-time two-way communication between the nervous system and external hardware to support natural movement and lifelike sensory experiences. By leveraging machine learning and advanced materials, BIOS aims to improve precision, responsiveness, and user adaptability in neuroprosthetic control systems.

BIOS’s technology is positioned for clinical and assistive use with individuals who have limb loss, offering a pathway to restore functional mobility and sensory feedback. The company’s work also intersects with research, rehabilitation, and broader assistive robotics ecosystems as it advances next-generation neural interfaces.

Brain-Computer Interface
Assistive Technology
Experimental

Neurofounders Insights

Modality:
Nerve stimulator
Form Factor:
Implant
Interface Depth:
Implantable
Indication:
Rehabilitation
Target user:
Patients
Regulatory stage:
Preclinical

Unknown

Biological Input Output Systems is differentiated by targeting the peripheral nervous system rather than the brain for its universal neural interface, avoiding craniotomy while enabling bidirectional prosthetic control through adaptive decoding algorithms. The company remains at an early and opaque stage with limited public disclosure on funding or regulatory progress, making its commercial trajectory difficult to assess.

Related companies

Articles featuring

Biological Input Output Systems

No articles yet!

Press releases

No press releases published yet.